The detection of serum ApoA-1 levels can be easily standardized to provide accuracy and reproducibility, strengthening the practical value of this test in contributing information for early decision making regarding the most effective therapy for each HCC patient. This evidence concerns the gene APOA1 and hepatocellular carcinoma.